porphyrin-polyamines (SLIL)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nameporphyrin-polyamines (SLIL)
Drug Alias Nameporphyrin-cyclic polyamine (SLIL)spermine derivatives (SLIL)CGC-11237SL-11162SL-11217 +[14] 
ClassificationSmall molecules
Mechanisms of ActionRadiosensitizers
TargetsUpdating
Therapy Area/IndicationsProstatic NeoplasmsBrain NeoplasmsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSLIL Biomedical Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSLIL Biomedical Corp
Active IndicationsN/A
Inactive IndicationsProstatic NeoplasmsBrain NeoplasmsPancreatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A